v3.26.1
SCHEDULE OF REPORTABLE SEGMENT LOSS (Details) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2026
Mar. 31, 2026
Jun. 30, 2025
Mar. 31, 2025
Jun. 30, 2026
Jun. 30, 2025
Research and development            
External research and development $ 317,979   $ 1,687,877   $ 677,169 $ 4,003,989
Internal personnel costs 45,148   479,237   177,092 973,965
Total research and development 363,127   2,167,114   854,261 4,977,954
General and administrative 1,445,739   2,289,649   3,114,193 4,051,368
Total operating expenses 1,808,866   4,456,763   3,968,454 9,029,322
Warrant repricing     (410,154)
Change in fair value of convertible promissory notes   (787,703)   (787,703)
Other income, net 14,003   15,547   42,675 55,676
Total other income (expense) 14,003   (772,156)   (367,479) (732,027)
Net loss $ (1,794,863) $ (2,541,070) $ (5,228,919) $ (4,532,430) $ (4,335,933) $ (9,761,349)